Considerations To Know About NIPT Scan
Cell-free DNA (cfDNA) arises from the natural breakdown of fetal cells (presumed to be mostly placental). The NIPT analyses cell-free DNA in the maternal blood which can suggest the likelihood of Down's syndrome (Trisomy 21), Edwards Syndrome (Trisomy 18) and Patau's Syndrome (Trisomy 13). On demand we can also yield a result for the gender of your infant, all from a maternal blood sample.
Extremely periodically it might include transvaginal/ internal scanning. Includes: 30 minute appointment A scan for viability (heartbeat) and gestation measurements A maternal blood sample (from the arm) taken into 2 sample bottles Ultrasound Direct toMOBILE delivery of your scan images and report Digital ultrasound report 2D ultrasound b/w prints in sleeve on the day, fetal DNA blood results approximately 7 working days later Plus complimentary sexing if requested either with ultrasound * (from 16 weeks pregnancy or later on) on get more at this site the day or consisted of with your blood test outcome (from 10 weeks) Plus 4DFREEVIEW (from 12 weeks) with 3D ultrasound b/w prints in sleeve ** If you wish to understand the sex of your child we will offer you our expert viewpoint with this scan If your infant's position is not favorable to do this on the day nevertheless, we can not use a totally free rescan for this purpose.
Please note that 4DFREEVIEW is a free alternative and if your infant's position is not favorable for aesthetics on the day, we can not use a totally free rescan for this factor. Need to expose lower abdominal area so ideally wear different garments i. e trousers or skirt and top. Consume 0. 5 Ltr (1 pint) clear fluid approx 1 hour before appointment time.
The NIPT is evaluated in the UK by our authorised partners: Consistency by means of TDL. In booking a NIPT consultation with us you are concurring to your personal details being shared with the appropriate partners solely for the function of this test. Your express approval will also be asked for during your consultation.